Cargando…

HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS

OBJECTIVE: Pleomorphic xanthoastrocytoma (PXA) with anaplasia is a rare histological subtype of central nervous system astrocytoma and generally treated as high grade gliomas. The optimal extent of therapy required is unknown. Here we report on 3 pediatric cases of PXA with anaplasia. We also descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronsley, Rebecca, Dunham, Christopher, Yip, Stephen, Hukin, Juliette, Cheng, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715475/
http://dx.doi.org/10.1093/neuonc/noaa222.316
_version_ 1783618964025245696
author Ronsley, Rebecca
Dunham, Christopher
Yip, Stephen
Hukin, Juliette
Cheng, Sylvia
author_facet Ronsley, Rebecca
Dunham, Christopher
Yip, Stephen
Hukin, Juliette
Cheng, Sylvia
author_sort Ronsley, Rebecca
collection PubMed
description OBJECTIVE: Pleomorphic xanthoastrocytoma (PXA) with anaplasia is a rare histological subtype of central nervous system astrocytoma and generally treated as high grade gliomas. The optimal extent of therapy required is unknown. Here we report on 3 pediatric cases of PXA with anaplasia. We also describe molecular features and methylation profile of PXA with anaplasia compared to age-matched PXA without anaplasia. METHODS: Our institutional database was queried for cases of PXA since 1998 and 3 cases with anaplasia were identified and records reviewed. RESULTS: 2/3 patients were male and all were aged 12 at diagnosis. All underwent a gross total resection (GTR), where the diagnosis of PXA with anaplasia was made. Immunohistochemistry demonstrated that two cases were BRAF V600E positive and two were CD34 positive. Methylation profiling revealed unique pattern of CpG methylation/unmethylation. All patients underwent 5400cGy radiation to the surgical bed. 2/3 patients received concurrent temozolamide with radiation followed by maintenance chemotherapy with temozolamide and lomustine for 6 cycles as per the Children’s Oncology Group Protocol ACNS0423. These two patients had a continued complete response. The third patient received temozolamide following radiation and subsequently had recurrent disease at the end of treatment and went on to have a re-resection GTR and achieved complete response after 6 cycles of lomustine, vincristine and procarbazine. All are alive with no evidence of disease at more than 2 years post treatment completion (OS=100%,EFS=67%). CONCLUSIONS: This rare pediatric tumor is not well understood. The genetic landscape may be informative for optimizing treatment and prognosis.
format Online
Article
Text
id pubmed-7715475
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77154752020-12-09 HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS Ronsley, Rebecca Dunham, Christopher Yip, Stephen Hukin, Juliette Cheng, Sylvia Neuro Oncol High Grade Glioma OBJECTIVE: Pleomorphic xanthoastrocytoma (PXA) with anaplasia is a rare histological subtype of central nervous system astrocytoma and generally treated as high grade gliomas. The optimal extent of therapy required is unknown. Here we report on 3 pediatric cases of PXA with anaplasia. We also describe molecular features and methylation profile of PXA with anaplasia compared to age-matched PXA without anaplasia. METHODS: Our institutional database was queried for cases of PXA since 1998 and 3 cases with anaplasia were identified and records reviewed. RESULTS: 2/3 patients were male and all were aged 12 at diagnosis. All underwent a gross total resection (GTR), where the diagnosis of PXA with anaplasia was made. Immunohistochemistry demonstrated that two cases were BRAF V600E positive and two were CD34 positive. Methylation profiling revealed unique pattern of CpG methylation/unmethylation. All patients underwent 5400cGy radiation to the surgical bed. 2/3 patients received concurrent temozolamide with radiation followed by maintenance chemotherapy with temozolamide and lomustine for 6 cycles as per the Children’s Oncology Group Protocol ACNS0423. These two patients had a continued complete response. The third patient received temozolamide following radiation and subsequently had recurrent disease at the end of treatment and went on to have a re-resection GTR and achieved complete response after 6 cycles of lomustine, vincristine and procarbazine. All are alive with no evidence of disease at more than 2 years post treatment completion (OS=100%,EFS=67%). CONCLUSIONS: This rare pediatric tumor is not well understood. The genetic landscape may be informative for optimizing treatment and prognosis. Oxford University Press 2020-12-04 /pmc/articles/PMC7715475/ http://dx.doi.org/10.1093/neuonc/noaa222.316 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle High Grade Glioma
Ronsley, Rebecca
Dunham, Christopher
Yip, Stephen
Hukin, Juliette
Cheng, Sylvia
HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title_full HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title_fullStr HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title_full_unstemmed HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title_short HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS
title_sort hgg-35. pediatric pleomorphic xanthoastrocytoma with anaplasia treated with surgery and adjuvant chemotherapy: a case series of 3 long-term survivors
topic High Grade Glioma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715475/
http://dx.doi.org/10.1093/neuonc/noaa222.316
work_keys_str_mv AT ronsleyrebecca hgg35pediatricpleomorphicxanthoastrocytomawithanaplasiatreatedwithsurgeryandadjuvantchemotherapyacaseseriesof3longtermsurvivors
AT dunhamchristopher hgg35pediatricpleomorphicxanthoastrocytomawithanaplasiatreatedwithsurgeryandadjuvantchemotherapyacaseseriesof3longtermsurvivors
AT yipstephen hgg35pediatricpleomorphicxanthoastrocytomawithanaplasiatreatedwithsurgeryandadjuvantchemotherapyacaseseriesof3longtermsurvivors
AT hukinjuliette hgg35pediatricpleomorphicxanthoastrocytomawithanaplasiatreatedwithsurgeryandadjuvantchemotherapyacaseseriesof3longtermsurvivors
AT chengsylvia hgg35pediatricpleomorphicxanthoastrocytomawithanaplasiatreatedwithsurgeryandadjuvantchemotherapyacaseseriesof3longtermsurvivors